The U.S. Navy commissioned David Schmidt, founder of Advanced Applications Group, to develop a device for sailors that would enhance their physical performance, leading to the creation of LifeWave’s groundbreaking technology. This innovation, initially designed for military use, has since evolved into a civilian product with claims of significant health benefits.
LifeWave’s flagship product, the X39 patch, utilizes phototherapy to stimulate cellular regeneration. According to users, it activates the body’s production of GHK-cu, a copper peptide linked to stem cell growth. Proponents argue that this process can reverse signs of aging, alleviate chronic pain, and improve overall vitality. Testimonials describe rapid relief from conditions such as lower back pain, knee discomfort, and stress-related ailments.
The technology has attracted attention from high-profile individuals, including RFK Jr., who reportedly uses the patch. Critics suggest that mainstream medical institutions may resist such innovations due to financial interests in traditional treatments like stem cell injections, which can cost up to $50,000 per session. LifeWave’s product, by contrast, is marketed as an affordable alternative.
Users also highlight the potential of complementary patches, such as the Aeon patch for inflammation reduction and IceWave for pain management. The company emphasizes its origins in military research, with some claiming that elite athletes and performers have adopted the technology for competitive advantages.
While scientific validation remains limited, the X39 patch continues to gain traction among those seeking non-invasive health solutions. Its development traces back to a U.S. Navy initiative aimed at optimizing sailor performance, now repurposed for public use.